West Oak Capital, LLC Eli Lilly & CO Transaction History

West Oak Capital, LLC

  • $2.83 Billion
  • Q4 2024

A detailed history of West Oak Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, West Oak Capital, LLC holds 5,762 shares of LLY stock, worth $4.28 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
5,762
Previous 500 1052.4%
Holding current value
$4.28 Million
Previous $44.5 Million -0.0%
% of portfolio
1.57%
Previous 1.57%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025
BUY
$727.2 - $932.06 $3.83 Million - $4.9 Million
5,262 Added 1052.4%
5,762 $44.5 Million
Q4 2024

Jan 10, 2025
SELL
$727.2 - $932.06 $3.88 Million - $4.98 Million
-5,342 Reduced 91.44%
500 $44.5 Million
Q3 2024

Oct 17, 2024
SELL
$772.14 - $960.02 $660,179 - $820,817
-855 Reduced 12.77%
5,842 $51.8 Million
Q2 2024

Jul 24, 2024
SELL
$724.87 - $909.04 $493,636 - $619,056
-681 Reduced 9.23%
6,697 $6.06 Million
Q1 2024

Apr 18, 2024
SELL
$592.2 - $792.28 $39,085 - $52,290
-66 Reduced 0.89%
7,378 $5.74 Million
Q4 2023

Jan 17, 2024
SELL
$525.19 - $619.13 $149,679 - $176,452
-285 Reduced 3.69%
7,444 $4.79 Million
Q3 2023

Oct 05, 2023
SELL
$434.7 - $599.3 $114,326 - $157,615
-263 Reduced 3.29%
7,729 $4.15 Million
Q2 2023

Jul 19, 2023
SELL
$350.74 - $468.98 $151,519 - $202,599
-432 Reduced 5.13%
7,992 $3.75 Million
Q1 2023

Apr 21, 2023
BUY
$310.63 - $364.82 $32,616 - $38,306
105 Added 1.26%
8,424 $2.89 Million
Q4 2022

Jan 05, 2023
SELL
$321.55 - $374.67 $131,835 - $153,614
-410 Reduced 4.7%
8,319 $3.04 Million
Q3 2022

Oct 28, 2022
SELL
$296.48 - $337.87 $498,086 - $567,621
-1,680 Reduced 16.14%
8,729 $2.82 Million
Q2 2022

Jul 11, 2022
SELL
$278.73 - $327.27 $280,402 - $329,233
-1,006 Reduced 8.81%
10,409 $3.38 Million
Q1 2022

Apr 20, 2022
SELL
$234.69 - $291.66 $68,060 - $84,581
-290 Reduced 2.48%
11,415 $3.27 Million
Q4 2021

Jan 12, 2022
SELL
$224.85 - $279.04 $89,940 - $111,616
-400 Reduced 3.3%
11,705 $3.23 Million
Q3 2021

Oct 07, 2021
SELL
$221.6 - $272.71 $212,736 - $261,801
-960 Reduced 7.35%
12,105 $2.8 Million
Q2 2021

Jul 20, 2021
BUY
$180.55 - $233.54 $1.23 Million - $1.6 Million
6,835 Added 109.71%
13,065 $3 Million
Q1 2021

Apr 13, 2021
SELL
$164.32 - $212.72 $27,934 - $36,162
-170 Reduced 2.66%
6,230 $1.16 Million
Q3 2020

Oct 09, 2020
SELL
$146.22 - $169.13 $40,941 - $47,356
-280 Reduced 4.19%
6,400 $947,000
Q2 2020

Jul 06, 2020
SELL
$136.42 - $164.18 $61,388 - $73,881
-450 Reduced 6.31%
6,680 $1.1 Million
Q1 2020

Apr 07, 2020
SELL
$119.05 - $147.35 $4,166 - $5,157
-35 Reduced 0.49%
7,130 $989,000
Q4 2019

Jan 09, 2020
BUY
$106.92 - $132.43 $192,990 - $239,036
1,805 Added 33.68%
7,165 $942,000
Q2 2019

Jul 12, 2019
SELL
$110.79 - $129.32 $4,431 - $5,172
-40 Reduced 0.74%
5,360 $594,000
Q1 2019

Apr 03, 2019
SELL
$111.31 - $131.02 $81,812 - $96,299
-735 Reduced 11.98%
5,400 $701,000
Q4 2018

Jan 08, 2019
SELL
$105.9 - $118.64 $10,590 - $11,864
-100 Reduced 1.6%
6,135 $710 Million
Q3 2018

Oct 04, 2018
SELL
$85.86 - $107.31 $7,727 - $9,657
-90 Reduced 1.42%
6,235 $669 Million
Q1 2018

Apr 05, 2018
BUY
$74.21 - $87.6 $9,276 - $10,950
125 Added 2.02%
6,325 $489 Million
Q4 2017

Jan 05, 2018
SELL
$81.94 - $87.89 $21,714 - $23,290
-265 Reduced 4.1%
6,200 $524 Million
Q3 2017

Oct 10, 2017
BUY
$77.07 - $85.54 $498,257 - $553,016
6,465
6,465 $553 Million

Others Institutions Holding LLY

# of Institutions
4,031
Shares Held
739M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $705B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track West Oak Capital, LLC Portfolio

Follow West Oak Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email